1. Home
  2. SBFM vs IBO Comparison

SBFM vs IBO Comparison

Compare SBFM & IBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SBFM
  • IBO
  • Stock Information
  • Founded
  • SBFM 2006
  • IBO 2018
  • Country
  • SBFM United States
  • IBO United States
  • Employees
  • SBFM N/A
  • IBO N/A
  • Industry
  • SBFM Biotechnology: Pharmaceutical Preparations
  • IBO
  • Sector
  • SBFM Health Care
  • IBO
  • Exchange
  • SBFM Nasdaq
  • IBO NYSE
  • Market Cap
  • SBFM 6.7M
  • IBO 5.8M
  • IPO Year
  • SBFM N/A
  • IBO 2024
  • Fundamental
  • Price
  • SBFM $1.57
  • IBO $0.70
  • Analyst Decision
  • SBFM Strong Buy
  • IBO
  • Analyst Count
  • SBFM 1
  • IBO 0
  • Target Price
  • SBFM $15.00
  • IBO N/A
  • AVG Volume (30 Days)
  • SBFM 196.4K
  • IBO 735.6K
  • Earning Date
  • SBFM 08-15-2025
  • IBO 08-23-2025
  • Dividend Yield
  • SBFM N/A
  • IBO N/A
  • EPS Growth
  • SBFM N/A
  • IBO N/A
  • EPS
  • SBFM N/A
  • IBO N/A
  • Revenue
  • SBFM $36,234,578.00
  • IBO N/A
  • Revenue This Year
  • SBFM $32.20
  • IBO N/A
  • Revenue Next Year
  • SBFM $32.74
  • IBO N/A
  • P/E Ratio
  • SBFM N/A
  • IBO N/A
  • Revenue Growth
  • SBFM 35.51
  • IBO N/A
  • 52 Week Low
  • SBFM $1.17
  • IBO $0.36
  • 52 Week High
  • SBFM $6.19
  • IBO $6.17
  • Technical
  • Relative Strength Index (RSI)
  • SBFM 53.18
  • IBO N/A
  • Support Level
  • SBFM $1.51
  • IBO N/A
  • Resistance Level
  • SBFM $1.61
  • IBO N/A
  • Average True Range (ATR)
  • SBFM 0.08
  • IBO 0.00
  • MACD
  • SBFM 0.00
  • IBO 0.00
  • Stochastic Oscillator
  • SBFM 78.48
  • IBO 0.00

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.

About IBO IMPACT BIOMEDICAL INC

Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.

Share on Social Networks: